ONCOLOGICAL PANEL DESIGN AND DEVELOPMENT
Argentys is supporting GenTerra JSC to develop the first regulatory-approved Next Generation Sequencing based diagnostic panel for oncology in Russia. Argentys is providing the complete bioinformatics support. This includes panel and oligo design, pipeline development and data interpretation & annotation software.
Argentys aims to advance and support the oncological field in Russia, and Europe as a whole, by supporting GenTerra.